Romny Scientific (United States)
- Research works
- 4 ▼ 67% vs 2013–17
- Citations
- 43 10.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 8% world 28%
Not ranked overall: Romny Scientific (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Romny Scientific (United States) publish most on?
By volume in 2022–2025: Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Glycogen Storage Diseases and Myoclonus and Sympathectomy and Hyperhidrosis Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Alzheimer's disease research and treatments Physiology 0 works
- 2 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
- 3 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
- 4 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
- 5 Mitochondrial Function and Pathology Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Romny Scientific (United States)'s research output changed?
Output in 2018–2022 was 67% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Bruno
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.